Evidence map›Paper›PMID 32327693›Full record

SynthesisCommunications biology2020

Predicted loss and gain of function mutations in ACO1 are associated with erythropoiesis.

Gudjon R Oskarsson, Asmundur Oddsson, Magnus K Magnusson, Ragnar P Kristjansson, Gisli H Halldorsson, Egil Ferkingstad, Florian Zink, Anna Helgadottir, Erna V Ivarsdottir, Gudny A Arnadottir and 28 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mechanisms controlling cellular and systemic iron homeostasis.Nature reviews. Molecular cell biology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Erythrocytosis associated withHaematologica · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 4 institutions in 3 countries.

Gudjon R Oskarsson *deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Asmundur Oddsson *deCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Magnus K Magnusson *deCODE genetics/Amgen Inc., Reykjavik, Iceland.
Ragnar P KristjanssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gisli H HalldorssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7067-9862
Egil FerkingstaddeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8090-7988
Florian ZinkdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Anna HelgadottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-1806-2467
Erna V IvarsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-2069-0681
Gudny A ArnadottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6571-423X
Brynjar O JenssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Hildigunnur KatrinardottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gardar SveinbjornssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Anna M KristinsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Amy L LeedeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jona SaemundsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Lilja StefansdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Jon K SigurdssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Olafur B DavidssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefania BenonisdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Aslaug JonasdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Adalbjorg JonasdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Stefan JonssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Reynir L GudmundssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Folkert W AsselbergsDepartment of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-1692-8669
Vinicius TragantedeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Bjarni GunnarssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gisli MassondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Gudmar ThorleifssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Thorunn RafnardeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-0491-7046
Hilma HolmdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.
Pall T OnundarsonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Daniel F GudbjartssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Gudmundur L NorddahldeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Patrick SulemdeCODE genetics/Amgen Inc., Reykjavik, Iceland. patrick.sulem@decode.is.ORCID http://orcid.org/0000-0001-7123-6123
Kari StefanssondeCODE genetics/Amgen Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID http://orcid.org/0000-0003-1676-864X
deCODE Genetics (Iceland) · ISNational University Hospital of Iceland · ISUniversity of Iceland · ISUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemoglobin is the essential oxygen-carrying molecule in humans and is regulated by cellular iron and oxygen sensing mechanisms. To search for novel variants associated with hemoglobin concentration, we performed genome-wide association studies of hemoglobin concentration using a combined set of 684,122 individuals from Iceland and the UK. Notably, we found seven novel variants, six rare coding and one common, at the ACO1 locus associating with either decreased or increased hemoglobin concentration. Of these variants, the missense Cys506Ser and the stop-gained Lys334Ter mutations are specific to eight and ten generation pedigrees, respectively, and have the two largest effects in the study (Effect

Indexed as

Gain of Function MutationLoss of Function MutationBiomarkersDatabases, GeneticErythropoiesisGenome-Wide Association StudyHemoglobinsHumansIcelandIron Regulatory Protein 1United KingdomACO1 protein, humanBiomarkersHemoglobinsIron Regulatory Protein 1

Identifiers

PMID32327693
PMCPMC7181819
OpenAlexW3020480996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.